, Ligand-Based Targeting of Apoptosis in Cancer: The Potential of Recombinant Human Apoptosis Ligand 2/Tumor Necrosis Factor???Related Apoptosis-Inducing Ligand (rhApo2L/TRAIL), Journal of Clinical Oncology, vol.26, issue.21, pp.3621-3630, 2008.
DOI : 10.1200/JCO.2007.15.7198
, Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells, Oncogene, vol.23, issue.55, pp.8979-8986, 2004.
DOI : 10.1038/sj.onc.1208086
, Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis, Medicinal Research Reviews, vol.280, issue.5, pp.688-714, 2008.
DOI : 10.1002/med.20123
, Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression, Experimental Cell Research, vol.314, issue.5, pp.1163-1176, 2008.
DOI : 10.1016/j.yexcr.2007.12.012
, TRAIL in cancer therapy: present and future challenges, Expert Opinion on Therapeutic Targets, vol.12, issue.10, pp.1299-1314, 2007.
DOI : 10.1136/gut.2004.056929
URL : https://hal.archives-ouvertes.fr/inserm-00527108
, Cytotoxicity of TRAIL/Anticancer Drug Combinations in Human Normal Cells, Annals of the New York Academy of Sciences, vol.170, issue.1, pp.209-216, 2006.
DOI : 10.1016/S0960-9822(06)00422-2
URL : https://hal.archives-ouvertes.fr/hal-00699955
, Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells, Biochemical Pharmacology, vol.76, issue.11, pp.1340-1351, 2008.
DOI : 10.1016/j.bcp.2008.07.031
, Death Receptor-Induced Activation of the Chk2- and Histone H2AX-Associated DNA Damage Response Pathways, Molecular and Cellular Biology, vol.29, issue.1, pp.68-82, 2009.
DOI : 10.1128/MCB.00581-08
, Baicalein Overcomes Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Resistance via Two Different Cell-Specific Pathways in Cancer Cells but not in Normal Cells, Cancer Research, vol.68, issue.21, pp.8918-8927, 2008.
DOI : 10.1158/0008-5472.CAN-08-1120